Literature DB >> 12182884

The neuropeptide Y receptors, Y1 and Y2, are transiently and differentially expressed in the developing cerebellum.

I Neveu1, S Rémy, P Naveilhan.   

Abstract

Neuropeptide Y (NPY), a peptide widely expressed in the brain, acts through the protein G-coupled receptors Y1, Y2 and Y5. In the adult rat, this peptide modulates many important functions such as the control of energy balance and anxiety. Its involvement in brain development has been less investigated. In the present study, we have analysed the expression of Y1 and Y2 in the developing rat cerebellum using RNase protection assay. Both receptors were detected in the embryo but at very low levels. Their expression then increased, reaching a peak at postnatal day 10. At later stages, we observed a down-regulation of both Y1 and Y2 mRNA levels. This pattern of expression was delayed in hypothyroid rats, suggesting that the regulation of NPY receptors was strictly related to cerebellar development stages. In situ hybridisation and immunohistochemistry analyses revealed specific localisations of the receptors. Y1 was exclusively expressed by Purkinje cells while Y2 was found mostly in granule cells of the internal granule cell layer. These observations argue in favour of specific roles for Y1 and Y2 in the developing cerebellum. In an initial attempt to characterise these roles, we have determined the number of apoptotic cells in the developing cerebellum of Y2(-/-) mice and analysed the effects of NPY on primary cultures of cerebellar granule neurones. Our data showed that the absence of Y2 did not increase cell death in the internal granule cell layer of the developing cerebellum, and that NPY by itself did not prevent the death of differentiated granule cells cultured in serum-free medium. However, we found that co-treatment of the cells by NPY and neuromediators such as NMDA or GABA strongly promoted the survival of granule neurones. Taken together, these observations suggest an involvement of the NPY receptors in cerebellar ontogenesis that remains to be demonstrated in vivo. Copyright 2002 IBRO

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12182884     DOI: 10.1016/s0306-4522(02)00256-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Overexpression of neuropeptide Y decreases responsiveness to neuropeptide Y.

Authors:  Katelynn M Corder; Qin Li; Mariana A Cortes; Aundrea F Bartley; Taylor R Davis; Lynn E Dobrunz
Journal:  Neuropeptides       Date:  2019-11-07       Impact factor: 3.286

2.  Activation of NPY type 5 receptors induces a long-lasting increase in spontaneous GABA release from cerebellar inhibitory interneurons.

Authors:  C J Dubois; P Ramamoorthy; M D Whim; S J Liu
Journal:  J Neurophysiol       Date:  2011-12-21       Impact factor: 2.714

3.  Flow cytometry protocols for surface and intracellular antigen analyses of neural cell types.

Authors:  Vishal Menon; Ria Thomas; Arun R Ghale; Christina Reinhard; Jan Pruszak
Journal:  J Vis Exp       Date:  2014-12-18       Impact factor: 1.355

4.  Distribution of neuropeptide Y-immunoreactive neurons in the human brainstem, cerebellum, and cortex during development.

Authors:  Sen Mun Wai; Pawel M Kindler; Edward T K Lam; Aiqun Zhang; David T Yew
Journal:  Cell Mol Neurobiol       Date:  2004-10       Impact factor: 5.046

5.  Cerebellum Transcriptome of Mice Bred for High Voluntary Activity Offers Insights into Locomotor Control and Reward-Dependent Behaviors.

Authors:  Kelsey Caetano-Anollés; Justin S Rhodes; Theodore Garland; Sam D Perez; Alvaro G Hernandez; Bruce R Southey; Sandra L Rodriguez-Zas
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.